| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.60B | 25.87B | 27.28B | 27.66B | 25.68B | 25.78B |
| Gross Profit | 21.34B | 21.43B | 22.39B | 22.85B | 21.09B | 21.33B |
| EBITDA | 8.05B | 7.74B | 13.28B | 12.23B | 11.19B | 11.78B |
| Net Income | 3.09B | 3.07B | -14.37B | 6.67B | 6.80B | 6.40B |
Balance Sheet | ||||||
| Total Assets | 110.23B | 118.90B | 118.72B | 153.55B | 137.37B | 137.69B |
| Cash, Cash Equivalents and Short-Term Investments | 4.89B | 5.81B | 2.96B | 4.03B | 3.27B | 3.38B |
| Total Debt | 35.33B | 36.95B | 39.73B | 43.14B | 39.66B | 43.97B |
| Total Liabilities | 63.05B | 68.90B | 65.78B | 77.84B | 69.96B | 74.73B |
| Stockholders Equity | 46.87B | 49.64B | 52.57B | 75.37B | 67.10B | 62.67B |
Cash Flow | ||||||
| Free Cash Flow | 8.67B | 9.52B | 10.25B | 9.87B | 9.19B | 9.28B |
| Operating Cash Flow | 9.27B | 10.13B | 10.71B | 10.39B | 9.72B | 9.79B |
| Investing Cash Flow | 954.00M | 1.38B | -296.00M | -705.00M | -1.14B | -783.00M |
| Financing Cash Flow | -11.39B | -10.63B | -9.31B | -8.88B | -8.75B | -7.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | $1.96B | 36.27 | 22.54% | 0.29% | 6.71% | 8.16% | |
67 Neutral | $2.83B | 28.22 | 4.56% | 0.34% | 61.64% | 16.76% | |
66 Neutral | $97.41B | 11.07 | ― | 7.05% | -0.96% | -11.42% | |
64 Neutral | $1.33B | 12.01 | 7.72% | 6.26% | 3.01% | -7.14% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $238.77B | 27.78 | ― | 3.52% | 7.72% | -12.45% | |
52 Neutral | $118.35B | 30.21 | 5.97% | 5.36% | 0.48% | ― |
British American Tobacco (BAT) is a leading global tobacco company, engaged in the production and sale of cigarettes, smokeless products, and other nicotine products, with a strong focus on innovation and new categories. In its latest half-year report, British American Tobacco announced a slight decline in reported revenue by 2.2% due to currency headwinds, but a 1.8% increase at constant exchange rates. The company highlighted a return to growth in the U.S. market, driven by the success of its Velo Plus product and improved performance in combustibles. Key financial metrics showed a 19.1% increase in reported profit from operations, with a significant rise in operating margin to 42.0%. The company’s smokeless products now account for 18.2% of group revenue, reflecting a strategic shift towards new categories. BAT’s management remains optimistic about meeting its full-year guidance, with expectations of continued growth in new categories and strong cash generation. The company is committed to delivering sustainable value for shareholders through strategic investments and a robust share buy-back program.